- 专利标题: Immunologically active proteins from Borrelia burgdorferi
-
申请号: US10762665申请日: 2004-01-22
-
公开(公告)号: US07083792B2公开(公告)日: 2006-08-01
- 发明人: Renate Fuchs , Bettina Wilske , Vera Preac-Mursic , Manfred Motz , Erwin Soutscheck
- 申请人: Renate Fuchs , Bettina Wilske , Vera Preac-Mursic , Manfred Motz , Erwin Soutscheck
- 申请人地址: DE
- 专利权人: Mikrogen Molekularbiologische Entwicklungs - GmbH
- 当前专利权人: Mikrogen Molekularbiologische Entwicklungs - GmbH
- 当前专利权人地址: DE
- 代理机构: Schwegman, Lundberg, Woessner & Kluth, P.A.
- 优先权: DE3942728 19891222; DE4018988 19900613; EPPCT/EP90/02282 19901221
- 主分类号: A61K39/00
- IPC分类号: A61K39/00 ; A61K39/02 ; C07K1/00 ; C07K14/00
摘要:
Various immunologically active proteins from Borrelia burgdorferi have been prepared by genetic manipulation in microorganisms. To do this, the specific DNA sequences were selected from a B. burgdorferi gene bank using suitable screening methods, or were prepared directly by DNA amplification using selected hybridization probes, and were placed under the control of inducible promoters such as, for example, the lac promoter. It has been possible, owing to description of efficient purification methods for the expressed antigens, to provide the proteins in a suitable way. These proteins can be used to produce specific and sensitive diagnostic assay kits. The specific combination of the immunologically active proteins makes precise diagnosis possible. Furthermore, monoclonal antibodies have been generated and are used as reagents for detecting pathogens directly in test samples or after cultivation. The Borrelia burgdorferi-specific DNA sequences can be employed for direct detection of the pathogen in patients' samples (for example by means of the PCR reaction).
公开/授权文献
信息查询